ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,464Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 761

$542K Total Retail Price of All Prescriptions

Rank: 102 out of 761

525 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 525 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

21% of this provider’s 525 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 10,428 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
FUROSEMIDE 549 524 1 7
LEVOTHYROXINE SODIUM 536 496 2 3
OMEPRAZOLE 494 426 3 4
SIMVASTATIN 425 388 4 2
ATENOLOL 388 368 5 8
METOPROLOL SUCCINATE 340 315 6 16
LOSARTAN POTASSIUM 336 294 7 13
HYDROCODONE-ACETAMINOPHEN 322 275 S3 8 5
POTASSIUM CHLORIDE 319 299 9 18
ATORVASTATIN CALCIUM 278 256 10 12
WARFARIN SODIUM 276 235 11 9
LISINOPRIL 269 256 12 1
AMLODIPINE BESYLATE 258 240 13 6
LOVASTATIN 237 170 14 17
METOPROLOL TARTRATE 213 204 15 14
HYDROCHLOROTHIAZIDE 181 166 16 11
ALLOPURINOL 175 169 17 28
KLOR-CON 10 165 163 18 74
FLUOXETINE HCL 160 145 19 31
METFORMIN HCL ER 149 132 20 67
PREDNISONE 130 121 21 30
SPIRONOLACTONE 120 114 22 45
SERTRALINE HCL 116 105 23 25
LOSARTAN-HYDROCHLOROTHIAZIDE 113 108 24 65
GLYBURIDE 91 90 R 25 77
PRAVASTATIN SODIUM 89 86 26 20
CITALOPRAM HBR 77 64 27 19
KLOR-CON M20 75 75 28 99
SYNTHROID 75 56 28 64
BENICAR 70 70 30 81
CRESTOR 70 64 30 36
TRIAMTERENE-HCTZ 69 69 32 42
METFORMIN HCL 67 56 33 10
AZITHROMYCIN 65 57 34 70
NAMENDA 64 64 35 59
DIGOXIN 63 60 36 43
SPIRONOLACTONE-HCTZ 62 48 37 177
OXYCODONE HCL 62 57 S2 37 24
CARVEDILOL 60 54 39 26
ADVAIR DISKUS 57 50 40 37
GABAPENTIN 57 53 40 15
DOXEPIN HCL 56 56 42 205
FLUTICASONE PROPIONATE 56 47 42 29
CYCLOBENZAPRINE HCL 56 38 R 42 51
LANTUS 56 49 42 41
VERAPAMIL ER 56 52 42 109
CLOPIDOGREL 51 43 47 66
ZOLPIDEM TARTRATE 51 39 47 22
NEXIUM 51 51 47 98
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 48 47 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.